This refers to problems caused by using strong pain medicines too much or taking them without a prescription. These can include addiction, dependence, and misuse of the drugs.
Every report comes from a Lived member, sent anonymously.
Have you tried Suboxone (Buprenorphine / Naloxone) for Opioid-Related Disorders?
Opioid-related disorders are health problems caused by using opioids, a family of drugs that includes prescription pain relievers such as oxycodone, hydrocodone and fentanyl, as well as heroin and illegally made fentanyl. The central one is opioid use disorder (OUD), often called opioid addiction: a pattern of use that a person finds hard to control and that keeps causing harm or distress in daily life. The umbrella also includes opioid withdrawal, the aches, sweating, diarrhea, restlessness and other symptoms that follow stopping or cutting back after regular use. It helps to separate dependence from addiction. Physical dependence means the body has adapted to the drug, so withdrawal happens without it. That can occur in anyone who takes opioids regularly, including as prescribed. Addiction is different: use continues compulsively despite the harm it causes. OUD matters because opioids slow breathing, and an overdose can be fatal. Illegally made fentanyl now drives most overdose deaths in the United States. OUD is also highly treatable, and treatment substantially lowers the risk of dying.
OUD can only develop after exposure to opioids, but most people who take an opioid do not develop it. Repeated use changes how the brain responds to reward and stress, and whether that turns into addiction depends on a mix of genetic, environmental and developmental factors. Risk is higher when opioids are misused, meaning taken in larger amounts or more often than prescribed, taken to get high, or taken from someone else's prescription. Long-term opioid treatment for pain also carries some risk, and that risk rises with higher doses. Other factors associated with addiction include untreated depression, anxiety or ADHD (attention-deficit/hyperactivity disorder), stressful or traumatic early life experiences such as childhood abuse, starting drug use at a young age, and having another substance use disorder. These factors make OUD more likely; none of them guarantees it, and having OUD is not a failure of willpower or character.
No blood test or scan diagnoses OUD. A clinician talks with the person about their opioid use over the past year and compares it with 11 standard criteria from the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders), the reference most US clinicians use. The criteria cover loss of control (using more or longer than intended, wanting or failing to cut down, spending a lot of time getting, using or recovering), craving, consequences (falling behind at work, school or home, continuing despite relationship or health problems, giving up important activities, using in physically dangerous situations), and the body's adaptation (tolerance, meaning the same amount has less effect, and withdrawal). Meeting at least two criteria within 12 months establishes OUD. Two or three is considered mild, four or five moderate, and six or more severe, and severity helps guide how intensive treatment should be. Tolerance and withdrawal do not count for someone taking opioids as prescribed under medical supervision, so a person on long-term pain treatment who is physically dependent does not have OUD for that reason alone. Clinicians also ask about alcohol and other drugs, and about mental health, because these often occur alongside OUD and shape the treatment plan.
The most effective treatment is medication for opioid use disorder (MOUD), usually alongside counseling and other support. Three medicines are approved by the US Food and Drug Administration (FDA) for OUD. Buprenorphine and methadone act on the same brain receptors as other opioids but in a steadier, controlled way, which relieves withdrawal and cravings without producing a high at a stable dose. Studies following large groups of people found that the risk of dying while on either medicine was less than half the risk when not on treatment, and guidelines treat both as first-line options. Taking them is treatment, not trading one addiction for another, and many people stay on them for months, years or longer. Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors only partway, which makes it safer in overdose. Any clinician who can prescribe controlled medicines, including primary care clinicians, can prescribe it. It comes as a film or tablet dissolved under the tongue, often combined with naloxone (as in Suboxone or Zubsolv), or as a weekly or monthly injection (Sublocade, Brixadi). It is usually started once early withdrawal has begun, because taking it while other opioids are still active can bring on sudden withdrawal. Methadone is a full, long-acting opioid agonist taken daily by mouth. For OUD it is dispensed only through certified opioid treatment programs, which typically means frequent or daily clinic visits at first, with take-home doses after a period of stability. Doses are raised gradually, since the first weeks carry a higher risk of overdose, and some medicines interact with methadone to affect heart rhythm. Naltrexone, given as a monthly injection (Vivitrol), works differently. It blocks the effects of opioids rather than relieving withdrawal, and it can only be started after about 7 to 10 days without opioids. Evidence for it is weaker than for buprenorphine and methadone, but it suits some people who have already stopped using. Medically supervised withdrawal, sometimes called detox, can be eased with medicines such as lofexidine (Lucemyra), a non-opioid drug for withdrawal symptoms. Detox on its own is not recommended as treatment, because people who stop without ongoing medication face a higher risk of returning to use and of fatal overdose. Counseling approaches such as cognitive behavioral therapy and contingency management (rewards for meeting treatment goals), along with peer groups such as Narcotics Anonymous, can help people build skills and stay in treatment, but they should not replace medication. During pregnancy, buprenorphine or methadone should be started as early as possible, and opioids should not be stopped suddenly. Everyone with OUD, and the people they live with, should have naloxone, a medicine that reverses an overdose. Narcan nasal spray has been sold without a prescription since 2023.
OUD is usually a long-term condition. Like other chronic illnesses, it can be managed well, but the brain changes it involves are lasting, so the chance of returning to use can persist even after years of recovery. A return to use is a reason to revisit the plan with the care team, not a sign that treatment is pointless. Many people find that once their dose is stable, cravings and withdrawal fade enough to focus on work, family and health again. The routine depends on the medicine. Methadone usually means regular clinic visits, which can be demanding at first and ease as take-home doses are earned. Buprenorphine is more often managed through office visits and a pharmacy, with injections as an option for people who prefer not to take a daily dose. The most dangerous times are often transitions. After stopping medication, finishing a detox program or any stretch without opioids, tolerance drops quickly, so an amount that was once usual can cause a fatal overdose. Death rates are several times higher in the first weeks after treatment stops. Anyone thinking of stopping medication should plan it with their prescriber. Combining opioids with alcohol, benzodiazepines such as alprazolam (Xanax) or other sedatives also raises the risk of dangerously slowed breathing, and the unregulated drug supply can contain fentanyl without the user knowing. Keeping naloxone where others can find it is part of everyday safety.
Talk to a clinician if opioid use feels hard to control, if you are taking prescribed opioids in larger amounts or more often than directed, or if cravings or withdrawal are shaping your day. Treatment can begin quickly, often in a primary care office. Contact your prescriber or treatment program promptly if you return to use, have strong cravings or withdrawal between doses, want to stop or change your medication, or become pregnant. If you are pregnant, do not stop opioids suddenly; ask for help starting or continuing treatment. Call 911 right away if someone cannot be woken or cannot speak, has slow, shallow or stopped breathing, has blue or purple lips or fingernails, or is making gurgling or choking sounds. Give naloxone if it is available, and start CPR if breathing has stopped or is very weak.
Last reviewed • Oct 2026
Educational content, not medical advice.
Becoming and Addiction isnt your fault staying there is.